Navigation Links
Life Technologies Announces First Quarter 2011 Results
Date:4/26/2011

CARLSBAD, Calif., April 26, 2011 /PRNewswire/ -- Life Technologies Corporation (NASDAQ: LIFE) today announced results for its first quarter ending March 31, 2011. Non-GAAP revenue for the first quarter was $897 million, an increase of 1 percent over the $887 million reported for the first quarter of 2010. Organic revenue growth for the quarter was flat compared to the same period prior year, due to the impact of difficult year over year comparables and the extraordinary events that occurred in Japan. Excluding these items, organic growth for the quarter was 5 percent.

(Logo: http://photos.prnewswire.com/prnh/20110216/MM49339LOGO)

"Our ability to drive performance is a direct result of our commitment to innovation and operational excellence," said Gregory T. Lucier, Chairman and Chief Executive Officer of Life Technologies. "We continue to invest in important new products and emerging markets while working to become ever more efficient in our operations.  We have laid the groundwork to accelerate both revenue and earnings in the remainder of the year and we are on track to meet our full year financial goals."

Analysis of First Quarter 2011 ResultsFirst quarter non-GAAP 2011 revenue increased
percent over the previous year.  Revenue growth without the impact from currency, completed acquisitions and divestitures was flat.  

  • Foreign currency exchange had a negative 1 point impact and prior acquisitions and divestitures contributed approximately 2 points to reported revenue growth.
  • Non-GAAP gross margin in the first quarter was 66.3 percent, 200 basis points lower than the same period prior year due to the negative impact from currency and mix partially offset by the positive impact of price.
  • Non-GAAP operating margin was 28.2 percent
    '/>"/>

  • SOURCE Life Technologies Corporation
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12

    Related biology technology :

    1. BioSpecifics Technologies Corp. Reports Second Quarter 2008 Financial Results
    2. RainDance Technologies Appoints Olex Vice President, System Development
    3. Palatin Technologies, Inc. Reports Positive Results of Phase 2a Clinical Study with PL-3994 for the Treatment of Heart Failure
    4. Reliant Technologies Announces Canadian Launch of Fraxel re:pair(R) Laser: A New Class of Treatment Therapy for CO2 Laser Skin Resurfacing
    5. RF Technologies(R) Installs Safe Place(R) Solution for Pediatric and Infant Security at ProHealth Cares Waukesha Memorial Hospital
    6. Sonus Pharmaceuticals and OncoGenex Technologies complete business combination; OncoGenex Pharmaceuticals to commence trading on NASDAQ Capital Market today
    7. Cryo-Cell International and EndGenitor Technologies Announce Research Collaboration
    8. Anthill Technologies Announces Agreement With Zafgen
    9. Neptune Technologies Reports Record Fiscal 2008 Fourth Quarter and Year End Results
    10. BioSpecifics Technologies Corp. Buys Down Royalties for Peyronies Disease
    11. Neptune Technologies successfully completes up to $8.5 million debt financing with Desjardins Group
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:1/15/2014)... Cynvenio, a cancer diagnostics company focused ... analysis of tumor cells in the bloodstream, today announced ... decision support application powered by CollabRx, Inc. , ... test, Therapy Finder will provide breast cancer patients and ...
    (Date:1/15/2014)... More than 5 million Americans are ... 3 seniors will die with Alzheimer’s or another dementia, ... have shocked many Americans into looking for ways to ... tragic age-related cognitive disorders. Jonathan Weisman, president of Biohack ...
    (Date:1/15/2014)... Freeslate, Inc ., the leading provider of ... one of India’s top five pharmaceutical companies, has received ... for high throughput solid form screening. , Lupin, ... range of quality, affordable generic and branded formulations and ...
    (Date:1/14/2014)... 2014 Histogen, Inc., a regenerative medicine ... grown under simulated embryonic conditions, today announced that they ... Medical, Inc. for physician-dispensed aesthetic products containing Histogen’s proprietary ... agreement is an amendment to the existing license between ...
    Breaking Biology Technology:Cynvenio Offers New Breast Cancer Therapy Finder Application for its ClearID Breast Cancer Genomic Test 2Cynvenio Offers New Breast Cancer Therapy Finder Application for its ClearID Breast Cancer Genomic Test 3Biohack Pure Offers 5 Tips for Increasing Memory in 2014 2Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 2Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 3Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 2Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 3
    ... June 25 Lixte,Biotechnology Holdings (OTC Bulletin Board: ... Disorders and Stroke (NINDS), National,Institutes of Health (NIH) ... and Development Agreement (CRADA) to develop,drugs for the ... March,2006 was extended through September 2009., Dr. ...
    ... titled “Avanta AC™ Advanced Ceramics Solutions as ... white paper outlines the challenges in manufacturing ... as well as the advantages of SACHEM’s ... are critical to a variety of leading ...
    ... (OTCBB:BTIM) and BioTime’s wholly-owned subsidiary Embryome Sciences, ... agreement with International Stem Cell Corporation (OTCBB:ISCO) ... (Lifeline) to jointly produce and distribute hundreds ... cell lines, along with corresponding data and ...
    Cached Biology Technology:Lixte Biotechnology Holdings Announces Extension of Its Cooperative Research and Development Agreement With The National Institute of Neurological Disorders and Stroke, National Institutes of Health, for Development of Anti-Brain Cancer Drugs 2Lixte Biotechnology Holdings Announces Extension of Its Cooperative Research and Development Agreement With The National Institute of Neurological Disorders and Stroke, National Institutes of Health, for Development of Anti-Brain Cancer Drugs 3 SACHEM Launches New Products for High Purity Advanced Ceramic Powders : Avanta AC™ Advanced Ceramics Solutions Offer Unique Advantages over Inorganic Bases in the Manufacture of Advanced Ceramic Nanoparticles 2 BioTime, Inc. and Embryome Sciences, Inc. Sign Agreement With International Stem Cell Corporation to Provide Unique Human Stem Cell Lines for Research Use 2 BioTime, Inc. and Embryome Sciences, Inc. Sign Agreement With International Stem Cell Corporation to Provide Unique Human Stem Cell Lines for Research Use 3 BioTime, Inc. and Embryome Sciences, Inc. Sign Agreement With International Stem Cell Corporation to Provide Unique Human Stem Cell Lines for Research Use 4 BioTime, Inc. and Embryome Sciences, Inc. Sign Agreement With International Stem Cell Corporation to Provide Unique Human Stem Cell Lines for Research Use 5
    (Date:4/18/2014)... adds a twist to the story of how barnyard chickens ... 21 in the journal Proceedings of the National Academy ... chickens that lived 200-2300 years ago in Europe, researchers report ... have looked far different from the chickens we know today. ... associate with modern domestic chickens -- such as their yellowish ...
    (Date:4/17/2014)... Ill. A drug under clinical trials to treat ... broad-spectrum drugs that act against various bacteria, fungal infections ... by University of Illinois chemists and collaborators. , Led ... team determined the different ways the drug SQ109 attacks ... to target other pathogens from yeast to malaria ...
    (Date:4/17/2014)... suggests that fish consumption advisories for expecting mothers ... contaminants like persistent organic pollutants (POPs). , ... including University of Toronto Scarborough PhD student Matt ... different levels of environmental contamination, a mother,s compliance ... the body influenced exposure in her children. , ...
    Breaking Biology News(10 mins):Ancient DNA offers clues to how barnyard chickens came to be 2Multitarget TB drug could treat other diseases, evade resistance 2Fish consumption advisories fail to cover all types of contaminants 2
    ... sp. DN1 , which may prove to be ... snow fields of the Rocky Mountains. Research examining this new ... DN1 was found to grow at temperatures approaching freezing ... sp. DN1 produces the highest quantity of lipids when ...
    ... into two species, the one-humped dromedary and the two-humped ... camels are precious in desert regions throughout the world. ... makes them ideally suited for transportation. In addition, camels ... without food and water. Despite the extremely arid conditions, ...
    ... AURORA, Colo. (May 27, 2013) A new study ... caused a significant spike in the number of young ... and beverages. "We have seen an increase in ... of drugs laws in Colorado," said George Wang, MD, ...
    Cached Biology News:Decoding the genome of the camel 2Surge in children accidentally eating marijuana-laced foods 2Surge in children accidentally eating marijuana-laced foods 3
    Desmosomal Protein Immunogen: Full length, native protein purified from human epidermal keratins. Storage: -20 C, Avoid Freeze/Thaw Cycles...
    Mouse monoclonal [SPM217] to Secretory Component Glycoprotein ( Abpromise for all tested applications)....
    Mouse monoclonal [3G8] to MDMA ( Abpromise for all tested applications)....
    Shh Antibody Shipping Temperature: HOT Storage Temperature: -20C...
    Biology Products: